Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Revolutionizing drug discovery: The impact of artificial intelligence on advancements in pharmacology and the pharmaceutical industry
Seema Yadav, Abhishek Singh, Rishika Singhal, et al.
Intelligent Pharmacy (2024) Vol. 2, Iss. 3, pp. 367-380
Open Access | Times Cited: 18

Showing 18 citing articles:

Advances in artificial intelligence for drug delivery and development: A comprehensive review
Amol D. Gholap, Md Jasim Uddin, Md. Faiyazuddin, et al.
Computers in Biology and Medicine (2024) Vol. 178, pp. 108702-108702
Closed Access | Times Cited: 17
Innovative Approaches in Regulatory Affairs: Leveraging Artificial Intelligence and Machine Learning for Efficient Compliance and Decision-Making
C. S. Ajmal, Sravani Yerram, V. Abishek, et al.
The AAPS Journal (2025) Vol. 27, Iss. 1
Closed Access
Volatile Organic Compound–Drug Receptor Interactions: A Potential Tool for Drug Design in the Search for Remedies for Increasing Toxic Occupational Exposure
John Onyebuchi Ogbodo, Simeon Ikechukwu Egba, Gavin C. Ikechukwu, et al.
Processes (2025) Vol. 13, Iss. 1, pp. 154-154
Open Access
AI in autoimmune diseases: Transforming diagnosis and treatment
Dipali Vikas Mane, A Deshmukh, Rohit Hanumant Ambare, et al.
Journal of Pharmaceutical and Biological Sciences (2025) Vol. 12, Iss. 2, pp. 109-118
Closed Access
AI-powered drug discovery for neglected diseases: accelerating public health solutions in the developing world
MD Nahid Hassan Nishan
Journal of Global Health (2025) Vol. 15
Open Access
Artificial Intelligence, Computational Tools and Robotics for Drug Discovery, Development, and Delivery
Ayodele James Oyejide, Yemi A. Adekunle, Oluwatosin David Abodunrin, et al.
Intelligent Pharmacy (2025)
Open Access
Utility of Artificial Intelligence in Antibiotic Development: Accelerating Discovery in the Age of Resistance
Esteban Zavaleta‐Monestel, Carolina Rojas-Chinchilla, Jeimy Campos-Hernández, et al.
Cureus (2025)
Open Access
<b>Memanfaatkan Kecerdasan Buatan dan Pembelajaran Mesin dalam Inovasi Farmasi</b>
Raymond R. Tjandrawinata
MEDICINUS (2025) Vol. 38, Iss. 2, pp. 28-35
Open Access
The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges
Chiranjib Chakraborty, Manojit Bhattacharya, Sang‐Soo Lee, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102295-102295
Open Access | Times Cited: 5
Artificial Intelligence in Head and Neck Cancer: Innovations, Applications, and Future Directions
Tuan D. Pham, Muy‐Teck Teh, Domniki Chatzopoulou, et al.
Current Oncology (2024) Vol. 31, Iss. 9, pp. 5255-5290
Open Access | Times Cited: 4
The Role of AI in Drug Discovery
M.K.G. Abbas, Abrar Rassam, Fatima Karamshahi, et al.
ChemBioChem (2024) Vol. 25, Iss. 14
Open Access | Times Cited: 3
Artificial intelligence as a tool in drug discovery and development
Maria Kokudeva, Mincho Vichev, Emilia Naseva, et al.
World Journal of Experimental Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 3
How AI Can Revolutionize the Pharmaceutical Industry
Pallav Dave
Journal of Drug Delivery and Therapeutics (2024) Vol. 14, Iss. 6, pp. 179-183
Open Access | Times Cited: 2
Advanced drug delivery technologies for postmenopausal effects
Shadab Md, Sabna Kotta
Journal of Controlled Release (2024) Vol. 373, pp. 426-446
Closed Access | Times Cited: 1
Advancements in Virtual Bioequivalence: A Systematic Review of Computational Methods and Regulatory Perspectives in the Pharmaceutical Industry
Nasser Alotaiq, Doni Dermawan
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1414-1414
Open Access | Times Cited: 1
Perspectives on managing non-communicable diseases in pediatric health using artificial intelligence
Gian Vincenzo Zuccotti, Valeria Calcaterra
Minerva Pediatrics (2024) Vol. 76, Iss. 5
Closed Access
The Impact of Emerging Technologies on Pharmaceutical Process Design and Optimization in Africa: A Review
Rachael Olakunmi Ogunye, Donatus Chigozie Egwuatu, Peter Chidendu Anene, et al.
Journal of Pharmaceutical Research International (2024) Vol. 36, Iss. 9, pp. 46-60
Open Access
Artificial Intelligence: A Catalyst for Breakthroughs in Nanotechnology and Pharmaceutical Research
Bikash Medhi, Himanshu Sharma, Tamanna Kaundal, et al.
International Journal of Pharmaceutical Sciences and Nanotechnology (2024) Vol. 17, Iss. 4, pp. 7439-7445
Closed Access
Revolutionizing Pharmaceutical Sciences
Ch. Hima Bindu, Raveendra Babu, Sasidhar Bhimana, et al.
Advances in medical technologies and clinical practice book series (2024), pp. 217-246
Closed Access
Advanced High Throughput Screening Platforms in Drug Discovery
Chinmayi Joshi, Drashti Makwana
Advances in medical technologies and clinical practice book series (2024), pp. 35-74
Closed Access
AI-Enhanced Multi-Algorithm R Shiny App for Predictive Modeling and Analytics- A Case study of Alzheimer’s Disease Diagnostics (Preprint)
Samuel Kakraba, Wenzheng Han, Sudesh Srivastav, et al.
(2024)
Closed Access
Page 1

Scroll to top